- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-05-0057044

Sanogen Pharma Private Limited
About Sanogen Pharma Private Limited
Data last updated:
Sanogen Pharma Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 20 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2013PTC051369. Its GSTIN is 06AAUCS0337F1ZA (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Swatantra Bharat Kanya Lal Kaul and Meenu Swatantra Bharat Kaul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 242 New Palam Vihar Phase – 2 Block B, Gurgaon, Haryana, India – 122017.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.41 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹62,164 (net margin 2%) and EBITDA of ₹84,027 (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
Sanogen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0057044). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Sanogen Pharma
Contact details
Sanogen Pharma Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 242 New Palam Vihar Phase – 2 Block B, Gurgaon, Haryana, India – 122017
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Sanogen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanogen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sanogen Pharma Private Limited, buy the company report.
Financials of Sanogen Pharma Private Limited
FY 2025 filings availableSanogen Pharma Private Limited reported revenue of ₹30.41 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84,027 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62,164 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanogen Pharma Private Limited, buy the company report.
Board of directors of Sanogen Pharma Private Limited
Sanogen Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swatantra Bharat Kanya Lal Kaul | Director | 20 Dec 2013 | 12 Years 10 Months | Current |
| Meenu Swatantra Bharat Kaul | Director | 20 Dec 2013 | 12 Years 10 Months | Current |
Peer comparison
Sanogen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unimax Natural Stones Private Limited | ₹30.42 Lakh (FY 2016) | 54.0% | Alwar, Rajasthan, India | |||
| Metacoats Aluminium Private Limited | ₹30.42 Lakh (FY 2025) | 41.0% | Thiruvananthapuram, Kerala, India | |||
| Ansh Webtech Private Limited | ₹30.42 Lakh (FY 2024) | 3.0% | Lucknow, Uttar Pradesh, India | |||
| Serf Agro Indian Producer Company Limited | ₹30.42 Lakh (FY 2021) | 7.0% | Pilibhit, Uttar Pradesh, India | |||
| Bioclinical Pharmaceuticals Private Limited | ₹30.41 Lakh (FY 2022) | 47.0% | Pune, Maharashtra, India | |||
| Sanogen Pharma Private Limitedthis company | ₹30.41 Lakh (FY 2025) | ₹62,164 | 2% | 6.0% | Gurgaon, Haryana, India | |
| Asirbadh Agro Food Services Private Limited | ₹30.41 Lakh (FY 2024) | 51.0% | Rourkela, Odisha, India | |||
| Earthen Matter (OPC) Private Limited | ₹30.4 Lakh (FY 2022) | 230.0% | Udupi, Karnataka, India | |||
| Shakuntal Electrionics Private Limited | ₹30.4 Lakh (FY 2025) | 34.0% | Pune, Maharashtra, India | |||
| Lawrencedale Estates and Farms Private Limited | ₹30.39 Lakh (FY 2025) | -86.0% | Udhagamandalam, Tamil Nadu, India | |||
| Saikat Steels Pvt Ltd | ₹30.39 Lakh (FY 2025) | -62.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Sanogen Pharma Private Limited, buy the company report.
Auditor
Sanogen Pharma Private Limited is audited by ANIL MANDIRATTA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL MANDIRATTA | FY 2017 | 095347 |
Shareholding
The shareholding of Sanogen Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sanogen Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanogen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanogen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanogen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAUCS0337F1ZA | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanogen Pharma Private Limited, buy the company report.
Recent activity
Sanogen Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Meenu Swatantra Bharat Kaul was appointed as Director on 20 Dec 2013.
Frequently asked questions
Sanogen Pharma is an active private limited company based in Gurgaon, Haryana, India. The company works in retail trading, within the trading industry. It was incorporated on 20 December 2013 (13+ years old) and is registered under CIN U74999HR2013PTC051369.
Sanogen Pharma has 2 current directors:
- Swatantra Bharat Kanya Lal Kaul - Director
- Meenu Swatantra Bharat Kaul - Director
The latest financial statements of Sanogen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanogen Pharma is 06AAUCS0337F1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Sanogen Pharma is U74999HR2013PTC051369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanogen Pharma was incorporated on 20 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Sanogen Pharma by revenue are Unimax Natural Stones Private Limited, Metacoats Aluminium Private Limited, Ansh Webtech Private Limited, Serf Agro Indian Producer Company Limited, Bioclinical Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Meenu Swatantra Bharat Kaul was appointed as Director on 20 Dec 2013. Swatantra Bharat Kanya Lal Kaul was appointed as Director on 20 Dec 2013.
Yes, Sanogen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0057044).
The registered office of Sanogen Pharma is at B – 242 New Palam Vihar Phase – 2 Block B, Gurgaon, Haryana, India – 122017.
Sanogen Pharma operates in the trading industry, in the retail trading segment.